- UroToday Home
- Urologic Oncology
The Latest Research on CRPC with Bone Metastases
Recent Abstracts
-
Efficient Bone Metastasis Diagnosis in Bone Scintigraphy Using a Fast Convolutional Neural Network Architecture.CRPC w/ bone metastasesAugust 10, 2020
-
Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223.CRPC w/ bone metastasesAugust 6, 2020
-
Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases.CRPC w/ bone metastasesAugust 5, 2020
-
Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases.CRPC w/ bone metastasesJuly 21, 2020
-
Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.CRPC w/ bone metastasesJuly 20, 2020
-
Bone, a Secondary Growth Site of Breast and Prostate Carcinomas: Role of Osteocytes.CRPC w/ bone metastasesJuly 14, 2020
-
Incidence, prevalence, and outcomes of systemic malignancy with bone metastases.CRPC w/ bone metastasesJuly 13, 2020
-
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing.CRPC w/ bone metastasesJuly 12, 2020
-
Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.CRPC w/ bone metastasesJuly 12, 2020
-
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223.CRPC w/ bone metastasesJuly 12, 2020
Beyond the Abstracts
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015